Acute Iron Poisoning: Immediate Deferoxamine Chelation Required
In a girl with serum iron >500 µg/dL and hematemesis, immediate intravenous deferoxamine chelation therapy at 15 mg/kg/hour is the most appropriate treatment, along with aggressive supportive care for shock and gastrointestinal hemorrhage.
Clinical Context and Severity Assessment
This presentation represents severe acute iron poisoning. The serum iron level exceeding 500 µg/dL combined with hematemesis (blood-tinged vomiting) indicates:
- Direct corrosive injury to the gastrointestinal tract
- Systemic iron toxicity with potential for cardiovascular collapse
- High risk for metabolic acidosis, coagulopathy, and multi-organ failure
Serum iron levels >500 µg/dL are associated with severe toxicity and mandate chelation therapy 1, 2.
Immediate Treatment Algorithm
1. Chelation Therapy (Primary Treatment)
Deferoxamine (DFO) by continuous intravenous infusion:
- Dose: 15 mg/kg/hour in normal saline 3, 1
- Continue until serum iron normalizes and clinical improvement occurs
- Duration typically 24-48 hours, but may extend longer in severe cases 2
The appearance of "vin-rose" (pink) colored urine indicates ferrioxamine excretion, though this is not consistently seen and should not delay treatment 1.
2. Gastrointestinal Decontamination
- Gastric lavage with deferoxamine solution (2-5 g in 1 L water) and sodium bicarbonate if presenting within 1-2 hours 2
- Whole bowel irrigation with polyethylene glycol-electrolyte solution if radiopaque tablets visible on abdominal X-ray 2
- Obtain abdominal radiograph to identify retained iron tablets 1, 2
3. Aggressive Supportive Care
Cardiovascular support:
- Large-bore IV access for volume resuscitation
- Aggressive fluid replacement for shock (iron causes third-spacing and vasodilation)
- Blood pressure monitoring and vasopressor support if needed
Management of gastrointestinal hemorrhage:
- Type and crossmatch for packed red blood cells
- Transfuse PRBCs for significant hemorrhage and hemodynamic instability 2
- Monitor hemoglobin/hematocrit serially
Metabolic correction:
- Correct severe acidosis (pH <7.1) with sodium bicarbonate
- Monitor and correct coagulopathy (check PT/INR, PTT)
- Replace clotting factors if coagulopathy present 4
4. Laboratory Monitoring
Initial assessment:
- Serum iron level (though treatment should not be delayed)
- Complete blood count with differential
- Blood glucose (hyperglycemia >150 mg/dL indicates severe toxicity) 1
- Electrolytes, BUN, creatinine
- Liver function tests
- Coagulation studies (PT/INR, PTT)
- Arterial blood gas for acidosis
- Abdominal radiograph
Serial monitoring during treatment:
- Serum iron levels every 4-8 hours initially 2
- Continue chelation until serum iron <150 µg/dL and clinical improvement
- Monitor for hepatic necrosis (days 2-3) with liver enzymes
Critical Pitfalls to Avoid
Do not delay chelation therapy waiting for serum iron results—clinical presentation (hematemesis, estimated ingestion >60 mg/kg) mandates immediate treatment 1
Do not use intramuscular deferoxamine in severe poisoning—IV route is required for adequate chelation 2
Do not rely solely on initial serum iron if obtained early—levels may not peak until 4-6 hours post-ingestion
Monitor for late complications:
- Hepatic necrosis (days 2-4)
- Gastrointestinal scarring/obstruction (weeks later) 4
Prognostic Indicators
Poor prognostic signs requiring intensive care:
- Shock requiring vasopressors
- Coagulopathy (prothrombin index <50%) 1
- Severe metabolic acidosis
- Acute liver failure
- Coma 2
Context: Why This is NOT Chronic Iron Overload
The provided evidence about chronic iron overload management (hemochromatosis, transfusion-related overload) is not applicable to this acute poisoning scenario 3, 5, 3, 5. Acute iron ingestion requires immediate chelation at higher doses (15 mg/kg/hour) compared to chronic iron overload management. The pathophysiology, treatment urgency, and deferoxamine dosing differ completely between acute poisoning and chronic iron accumulation disorders.
This patient requires immediate transfer to a pediatric intensive care unit for continuous deferoxamine infusion, hemodynamic monitoring, and management of potential multi-organ failure 1.